UNVERIFIEDSingle SourceOpinion: I was a Theranos whistleblower. In ‘You Can See Everything,’ Elizabeth Holmes is still lyingStat News|10/19/2026
UNVERIFIEDSingle SourceSTAT+: China moves to restrict foreign biotech acquisitionsStat News|10/19/2026
UNVERIFIEDSingle SourceSTAT+: Gilead’s IBD drug eliminated symptoms for patients, mid-stage study findsStat News|10/19/2026
UNVERIFIEDSingle SourceSTAT+: Does Isomorphic Labs have what it takes to revolutionize drugmaking?Stat News|10/19/2026
UNVERIFIEDSingle SourceSTAT+: RevMed’s pancreatic cancer drug nears European approvalStat News|10/16/2026
UNVERIFIEDSingle SourceWhat to read before you go see that new documentary on Elizabeth HolmesStat News|10/16/2026
UNVERIFIEDSingle SourceMerck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine successStat News|10/15/2026
UNVERIFIEDSingle SourceSTAT+: Verastem’s KRAS inhibitor shows promise in pancreatic cancerStat News|10/15/2026
UNVERIFIEDSingle SourceAfter a melanoma diagnosis, mRNA cancer vaccine delivered a patient hope — and a path forwardStat News|10/15/2026
UNVERIFIEDSingle SourceSTAT+: On Wall Street, there’s trouble stirring for biotechStat News|10/15/2026
UNVERIFIEDSingle SourceSTAT+: FDA adcomm members’ ties to industry under scrutinyStat News|10/14/2026
UNVERIFIEDSingle SourceSTAT+: Concerns grow on safety issues tied to Neurocrine Biosciences rare disease drugStat News|10/13/2026
UNVERIFIEDSingle SourceSTAT+: Trump boast on drug pricing policy overstated state-level interest in federal programStat News|9/24/2026